Navigation Links
Mayo Clinic CEO Offers New Vision for Personalized Patient Care
Date:3/4/2009

WASHINGTON, March 4 /PRNewswire/ -- Denis A. Cortese, M.D., president and CEO of the Mayo Clinic, offered a new vision for personalized healthcare in America at a time when Congress and the administration are discussing changes in the healthcare system.

The Mayo Clinic is committed to implementing personalized medicine for its patients. By targeting specific treatments to individual patients based on an analysis of differences in their molecular makeup, personalized medicine increases the effectiveness and safety of many existing therapies and spurs the creation of new treatments.

Dr. Cortese was introduced by Paul Stoffels, M.D., company group chairman, global pharmaceutical research and development, Johnson & Johnson. Dr. Stoffels said that Johnson & Johnson is committed to a personalized approach to medicine, using its broad expertise in healthcare research and development to develop targeted therapies for major diseases.

The keynote address at the Personalized Medicine Coalition's annual luncheon took place against the backdrop of the Obama Administration's health reform summit, which the president announced last week in his address to Congress. Johnson & Johnson sponsored the luncheon, which was held at the National Press Club.

Dr. Cortese discussed how Mayo Clinic's implementation of personalized medicine works in practice and what it means for Mayo's patients. He emphasized the importance of interoperable computerized patient records and communication among different providers in determining the optimal treatments for individual patients.

"Health information technology plays a huge role in synthesizing large amounts of data, creating knowledge that will drive evidence-based decision making," Dr. Cortese said.

These insights should guide spending for two sums in the economic stimulus package: $19.2 billion for health information tech
'/>"/>

SOURCE Personalized Medicine Coalition
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
2. Enobia Completes Target Enrollment in Clinical Trial for Infantile Hypophosphatasia
3. Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform
4. Clinical Research Staffing Firm ASG Acquires CRO Ockham Development Group
5. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
6. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
7. Implicit Licenses Clinical Stage Antibody Program From Lilly
8. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
9. Charlotte Anti-Aging Expo & Symposium Supports Free Clinics
10. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
11. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and TEL AVIV, Israel , May ... the "Company") (NYSE MKT: NSPR), a leader in embolic protection ... Company,s President and Chief Executive Officer, and Craig ... in the Benchmark Company, LLC One-on-One Investor Conference on Thursday ... Ave., Milwaukee, WI. The ...
(Date:5/24/2013)... 2013 Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients, ... Ph.D., the Company,s Vice President, Biology and ... Corporate Communications, will present an overview of Senomyx,s technology ... Eastern Time (7:25 a.m. Pacific Time) during the Citi ...
(Date:5/24/2013)... This market report summarizes the industry-wide ... out in May 2013. The full report provides ... responses for each question, its segmentation and the ... some interesting differences, particularly between Pharma, Biotech and ... developed to estimate the in house and outsourced ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... Lessons. Legacy.") features,Carnegie-Mellon Professor,s fight against pancreatic cancer and underscores, his call-to-action ... ... debuts on heels of Lustgarten Foundation,s limited online book offer,as seen on ABC ... ...
... 17 Spherix Incorporated,(Nasdaq: SPEX ) announced the ... Brown will be monitoring and overseeing all aspects of ... Naturlose(R) as a,treatment for Type 2 diabetes. The hiring ... with the Contract Research Organization (CRO),take over full control ...
... BioMed Realty Trust, Inc.,(NYSE: BMR ) today ... of common stock at $25.50 per share. The offering ... Gross proceeds from the offering will be,approximately $145.4 million. ... to repay a portion of the outstanding indebtedness under ...
Cached Biology Technology:The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring 'Last Lecturer' Dr. Randy Pausch 2Spherix Hires Key Employees 2BioMed Realty Trust Prices Public Offering of 5,700,000 Shares of Common Stock 2BioMed Realty Trust Prices Public Offering of 5,700,000 Shares of Common Stock 3
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
(Date:5/24/2013)... have focused among other factors on drugs that ... the accumulation of A-beta that causes the known plaques in ... of A-beta is APP. Alessia Soldano and Bassem Hassan (VIB/KU ... the fruit-fly version of APP in the brain ... "We have discovered that APPL ensures that brain cells form ...
(Date:5/24/2013)... from around the world today issued a stark warning ... one or two generations, the majority of the 9 ... handicap of severe pressure on fresh water, an absolutely ... This handicap will be self-inflicted and is, we believe, ... underlying problems led by mismanagement and sent a prescription ...
Breaking Biology News(10 mins):Please do try this at home 2A new strategy required in the search for Alzheimer's drugs? 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4
... An investigation of the genes that govern spore formation in ... role in determining which of the microbes sacrifice themselves for ... B. subtilis, a common soil bacteria, is a well-known survivor. ... in colonies or encase itself in a tough, protective spore ...
... -- European breast cancer specialists have taken a ... by bringing together world leaders in breast cancer research ... IMPAKT (IMProving cAre and Knowledge in Translational research). ... May 2009 in Brussels, Belgium, is designed to present ...
... Versions Support Development of Web-based Applications, Live Face ... ... Biometric Identification, VILNIUS, ... high-precision biometric identification,technologies, today announced the availability of two ...
Cached Biology News:Are sacrificial bacteria altruistic or just unlucky? 2Improving care and knowledge in translational research to fight breast cancer 2VeriFinger 6.0 SDK for Fingerprint Recognition and VeriLook 3.2 SDK for Facial Recognition are Now Available 2VeriFinger 6.0 SDK for Fingerprint Recognition and VeriLook 3.2 SDK for Facial Recognition are Now Available 3
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Spaced cover glasses to promote effective hybridization...
prototype Nco I...
... via cardiac puncture from 3 to 4 week ... is then centrifuged and frozen at -70C. The ... at 4C then stored at -70C. DIRECT SALES ... PEL-FREEZ COMPLEMENT, YOU CAN NOW BUY DIRECTLY FROM ...
Biology Products: